We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.


Previous 10 Next 10 
From: PaperPerson8/7/2012 10:06:28 PM
   of 4690
Sandstorm Gold Reports Record Gold Sales and Operating Cash Flow in Q2, 2012
Press Release: Sandstorm Gold Ltd. – Thu, Jul 26, 2012 4:50 PM

VANCOUVER, BRITISH COLUMBIA--(Marketwire -07/26/12)- Sandstorm Gold Ltd. ("Sandstorm" or the "Company") (SSL.V) is pleased to announce its unaudited results for the second quarter ended June 30, 2012 (all figures in U.S. dollars).
Second Quarter Highlights

-- Record gold sales of 9,259 ounces.
-- Record operating cash flow of $11.3 million.
-- Average cash cost per ounce(1) of $298 resulting in cash operating
margins of $1,317 per ounce.
-- Net income of $5.3 million.
-- Sandstorm acquired from Magellan Minerals Ltd., a 2.5% net smelter
returns royalty on the Coringa gold project and a 1.0% NSR royalty on
the Cuiu Cuiu gold project.
-- Sandstorm acquired a 2.4% net smelter returns royalty on the Mt.
Hamilton gold project from Solitario Exploration & Royalty Corp. and Ely
Gold & Minerals Inc.

"Steady production growth from our mining partners has led to consecutive record quarters for Sandstorm," said President & CEO Nolan Watson. "During the second quarter we deployed our cash into royalty transactions that we believe will be accretive to shareholders, and the pipeline of potential gold streaming opportunities is stronger than ever."
Based on existing gold stream agreements, the forecasted attributable production for 2012 is 28,000 to 33,000 ounces of gold, increasing to over 50,000 ounces of gold per annum by 2015.
Further details of the individual commodity streams can be found within Management's Discussion and Analysis contained in the Company's second quarter 2012 report and on the Company website.
Webcast and Conference Call Details
A conference call will be held on Friday, July 27, 2012 starting at 8:30am PDT to further discuss the second quarter results. To participate in the conference call use the following dial-in numbers:
Local/International: 647-788-4916
North American Toll-Free: 877-214-4966
It is recommended that participants dial in five minutes prior to the commencement of the conference call. Click here to access an audio webcast of the conference call which will also be available on the Sandstorm website.
Sandstorm Gold Ltd. is a growth focused resource based company that seeks to complete gold purchase agreements with companies that have advanced stage development projects or operating mines. A gold purchase agreement involves Sandstorm making an upfront cash payment to its partners and in exchange, Sandstorm receives the right to purchase a percentage of the gold produced for the life of the mine, at a fixed price per ounce. Sandstorm helps other companies in the resource industry grow their business, while acquiring attractive assets in the process.
Sandstorm is focused on low cost operations with excellent exploration potential and strong management teams. Sandstorm has completed gold purchase or royalty agreements with Luna Gold Corp., SilverCrest Mines Inc., Santa Fe Gold Corp., Rambler Metals and Mining plc, Brigus Gold Corp., Metanor Resources Inc., Donner Metals Ltd., Magellan Minerals Ltd., Solitario Exploration & Royalty Corp. and Ely Gold & Minerals Inc.
For more information visit:

Share RecommendKeepReplyMark as Last Read

From: PaperPerson8/13/2012 5:34:18 PM
   of 4690
Claude Resources 2nd-qtr profit falls 88 pct as costs rise

Mon Aug 13, 2012 9:29am EDT

(Reuters) - Gold producer Claude Resources Inc cut its full-year production forecast after its second-quarter profit fell steeply due to higher costs and a fall in ore quality.

The Quebec-focused company cut its full-year production estimate to 48,000 to 50,000 ounces of gold from 50,000 to 52,000 ounces.

The company also said it expects per-unit cash costs to be higher by 10 percent in 2012.

Output at its only producing site, Seabee Gold Operation in northern Saskatchewan, fell 4 percent in the second quarter to 12,166 ounces, while production costs rose 50 percent to C$13.3 million.

Net profit fell to C$679,000 ($634,700), or a break even per share, from C$5.2 million, or 3 Canadian cents per share, a year earlier.

Revenue rose 10 percent to C$20.1 million on higher gold prices.

Gold price rose 7 percent during the second quarter from the year-ago period to average $1,611 per ounce.

Share RecommendKeepReplyMark as Last Read

From: PaperPerson8/14/2012 9:56:13 AM
   of 4690
Medical Marijuana, Inc. Closes with Lotus Capital for a $2 Million Equity Based Line of CreditPress Release: Medical Marijuana, Inc. – 1 hour 16 minutes ago

Medical Marijuana, Inc.

MJNA 0.0355 0.00

SAN DIEGO, Aug. 14, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) a leading hemp industry innovator, has announced that the Company has signed closing documentation for a $2 million USD line of credit with Lotus Capital, a Chicago based private equity firm. The line of credit will be used as a reserve fund for product expansion of the Dixie X line of Cannabidoil (CBD) based products as well as to support the national marketing campaign of the Dixie X and CanChew gum product launch, scheduled for early September. The LOC will also be available to support future expansion through Company acquisitions.

This new revolving line of credit will be secured against shares of the Company's Capital Stock. MJNA is in the process of providing a new S-1 registration statement for the issuance of the shares. Additional terms of the LOC allow MJNA to cancel the line at any time, releasing the security interest in the shares back to the Company. This transaction is non-dilutive to the shareholders providing that the Company repays any drawdown against the LOC per the terms of the agreement.

Revolving Line of Credit Uses

Currently, Company revenue sources are sufficient to meet operational cash-flow requirements. However, the Company anticipates increased costs to properly support the national launch of its hemp-based CBD Dixie-X and CanChew products. Additionally, we have numerous product and market expansion opportunities which require capital to execute. For these reasons, the Company has been exploring several financing options.

Medical Marijuana, Inc. President Michael Llamas was quoted: "Having this additional access to the capital markets gives us maximum flexibility to bring forth the best of the numerous business opportunities that lie before us. Although we have been extremely selective in our current business development, we foresee numerous potential expansion opportunities and want to be prepared for the future. We appreciate the continued support of our team and shareholders."

Company to become Fully Reporting

In conjunction with the S-1 filing, MJNA expects to file their first audited financial statements prior to year-end. The Company's objective is to complete the 15c2-11 application process, which it started in May of this year, as well as becoming a fully reporting, fully compliant company with the Securities Exchange Commission (SEC). The audit and due diligence process will take an additional 90 to 120 days to complete. Once completed and approved, the Company's equity shares will trade on a "Solicited" basis, be on a higher level of the NASD Over-the-Counter Bulletin Board and there will be a dedicated market maker for the Company's tradable shares.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana, Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at:

Share RecommendKeepReplyMark as Last Read

From: esalad8/15/2012 5:31:41 PM
   of 4690
Sandstorm Gold To List On the NYSE MKT LLC

Vancouver, British Columbia | August 15, 2012

Sandstorm Gold Ltd. (“Sandstorm” or the “Company”) (TSX-V: SSL) is pleased to announce that its common shares have been approved to list on the NYSE MKT LLC and will begin trading on August 20, 2012 under the symbol “SAND”. The Company’s common shares will continue to be listed on the TSX Venture exchange under the symbol “SSL”.

“This is an exciting milestone in the young history of Sandstorm”, said President and CEO Nolan Watson. “Trading on the NYSE MKT will give us the opportunity to attract a larger investor base in the U.S. and internationally.”

Members of the Sandstorm team will have the pleasure of ringing the NYSE Opening Bell on August 20, 2012.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

From: PaperPerson8/15/2012 7:32:41 PM
   of 4690
MJNA making a nice move above a three-cent one-year moving average. Fundamentals falling into place now that move has started.

Blue line is 50 week MA. On bakance volume line above and below office chart support validity of breakout.


Medical Marijuana, Inc. Reports Second Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1200 Percent From Same Period Last Year
Last update: 8/15/2012 9:37:00 AM
SAN DIEGO, Aug. 15, 2012 /PRNewswire via COMTEX/ -- Medical Marijuana, Inc. (MJNA), one of the medical marijuana (MMJ) industry's premier cannabis and hemp industry innovators, today announced its second quarter earnings. The company earned net income of approximately $1.47 million on gross revenues of $2.40 million for the quarter ended June 30, 2012. This represents a gross revenue increase of 1200 plus percent quarter-over-quarter when compared to revenue of $196,748 for the quarter ended June 30, 2011. Operating expenses and cost of goods sold totaled approximately $930,000 for the quarter.
Operational and development highlights
Operating highlights of the quarter were as follows:
Completed the acquisition of Dixie Elixirs & Edibles brand, intellectual property, proprietary formulas and extraction processes. In conjunction it formed Red Dice Holdings, as was announced in late April, to develop manufacturing and distribution partnerships for Dixie in every state and country that has legalized medical cannabis. Finalized national and international product development for Q 3 online and retail sales launch.
Begun hemp-based extraction product development beyond the medical marijuana industry, crossing into the nationally legal category of health and wellness with such products as sleep aids, topical and pain management. A market launch of the new products is expected by the end of the second quarter.
Brought PhytoSPHERE systems on-line and will begin to market the benefits of its seed-to-sale product growth and cultivation technology worldwide.
Completed Hemp Oil CBD production at facility "1". Commercialized and expanded production to meet next 12-24 month demand.
Completed the acquisition of CanCHEW Bio-Technologies, secured regional GMP manufacturing partner, as well as produced first U.S. based sample production.
Submitted company's portfolio of products to European Health Authorities for Over-The-Counter (OTC) approvals.
Started clinical development five of the fifty five products.
In addition, since the close of the second quarter, Medical Marijuana, Inc. has:
Finalized U.S. and International CBD product launch plan.
Produced over 35-million doses worth of CBD Oil for MJNA product sales.
Formally started the negotiations and final terms for the acquisition of a chain of retail health and wellness facilities in the U.S. with revenues in excess of $8.0 million annually.
Sold its first batch of commercialized CBD Oil.
Contracted for the production of 300KG of CBD oil for $7.5 million.
Sourced Arizona, California, European Dixie Brand and CanCHEW distribution partners.
Signed closing docs for Lotus Capital $2.0 million line of credit.
Comments regarding operations and outlook
"The second quarter of 2012 cemented Medical Marijuana, Inc.'s path," said Michael Llamas, President of Medical Marijuana, Inc. "We have spent this last year and a half essentially getting our house in order by clarifying the growth strategy and systematically identifying, acquiring and growing early stage companies across the spectrum of the MMJ and hemp industries from product development and production, to retail sales. As witnessed by our strong quarter-over-quarter and year-over-year growth, there is tremendous opportunity in this industry and that opportunity is growing rapidly at home and abroad. With the acquisition of the Dixie brand we have secured our product development, manufacturing, sales and customer services platform, which now enables the company to focus on developing its online sales and retail sales, while allowing MJNA to develop and acquire additional brands and integrate them seamlessly into our overall sales platform thus allowing our strong growth to continue. With the investment and development of CanCHEW, the company has cemented MJNA's place in the future cannabinoid pharmaceutical drug delivery system. We feel this is truly a revolutionary product."
"In 2012 we have continued to build a strong foundation in which grow the MJNA's portfolio. We appreciate the continued support of our dedicated team and shareholders," stated Michael Llamas, President of Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: esalad who wrote (4655)8/16/2012 8:16:27 AM
From: PaperPerson
   of 4690
Put and call options on SSL/SAND to come. Writing covered calls is an excellent way to safely generate income in a portfolio.

Share RecommendKeepReplyMark as Last Read

From: aknahow8/21/2012 11:43:20 PM
   of 4690
Negative implications for platinum. Indirect favorable for gold.

The night that platinum died?

Nanostellar's Mixed-Phase NO Oxidation Catalyst (Noxicat™) Continues to gain recognition among customers and scientific community Noxicat™ based paper published in the magazine Science: Mixed-Phase Oxide Catalyst Based on Mn-Mullite ( Sm, Gd)Mn2O5 for NO Oxidation in Diesel Exhaust
By Nanostellar, Inc.

Nanostellar, Inc.
Last modified: 2012-08-18T13:06:23Z

Published: Saturday, Aug. 18, 2012 - 6:06 am

Copyright 2012 . All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

REDWOOD CITY, Calif., Aug. 18, 2012 -- /PRNewswire/ -- Nanostellar, Inc., a company developing materials for automotive emissions control and other cleantech applications announced that a paper based on its Noxicat™ catalyst has been published in the August 2012 issue of Science. Noxicat™ has already received considerable interest from manufacturers of light-duty and heavy-duty diesel engines for its ability to help engine manufacturers reduce harmful greenhouse gas emissions while dramatically reducing the cost of doing so.

Oxides of nitrogen (NOx) produced during the combustion process in diesel engines are strictly regulated greenhouse gasses. Efficient conversion of NOx into nitrogen in vehicles using diesel engines requires oxidizing some NO into NO2. Currently, the industry practice is to use high levels of platinum, which saddles the engine manufacturers with extremely high cost and low stability under hydro-thermal conditions to which these systems are exposed.

"We achieved the goal of finding a NO oxidation catalyst that performs better than platinum, does not use any precious metals and is hydrothermally stable" remarked Geoffrey McCool, who invented this material. Noxicat™ is stable within diesel exhaust temperature range, while platinum based solutions tend to sinter and loose activity when exposed at temperatures higher than 750 degrees C. This novel material starts being active at temperatures as low as 120 degrees C with NO to NO2 conversion maxima of ~45% higher than that achieved with Pt after prolonged thermal aging. Structurally, the active site was found to be a Mn-Mn dimer on stepped mullite surfaces. "According to my density functional theory calculations, Noxicat's active site has a comparable rate limiting step to that of platinum," stated Weichao Wang, leading author of Science article.

"In addition to significantly reducing the costs of emissions control systems, Noxicat™ has numerous performance benefits over the incumbent platinum based catalysts" commented Pankaj Dhingra, Nanostellar's President and CEO. "Noxicat™ enables higher fuel efficiency by allowing engine designers to reduce the frequency of filter regeneration events and allows for redesign of the emissions control system for further optimization."

Dr. Bulent Yavuz, Nanostellar's vice president of sales and marketing who has been monitoring the reaction of early customers stated that "Noxicat™ has created an unprecedented level of excitement among heavy-duty diesel engine manufacturers for both its performance benefits and its promise of significant cost reductions. The commercialization efforts received a further boost when customer testing revealed that Noxicat™ is able to regenerate itself after exposure to fuel-borne sulfur."

About Nanostellar

Nanostellar develops advanced catalysts for emissions control and other cleantech applications. These solutions are developed using the Company's innovative Rational Design Methodology which incorporates computational methods, nano-materials synthesis expertise and strong characterization techniques.

In 2008 the World Economic Forum recognized Nanostellar as a Technology Pioneer, an honor it bestows on those companies whose innovations are expected to have a critical impact on the future of business and society. In 2011 Nanostellar was named as a top emerging catalyst company by Lux Research, an independent research and advisory firm providing strategic advice and on-going intelligence on emerging technologies.

The company is located in Silicon Valley, California, and is funded by venture capital and other private investors.

For more information, visit

Nanostellar is a registered trademark of Nanostellar, Inc. All other brands, products, or service names are or may be trademarks or service marks of their respective owners.

SOURCE Nanostellar, Inc.

Read more here:

Share RecommendKeepReplyMark as Last Read

To: PaperPerson who wrote (4656)9/1/2012 5:36:11 AM
From: PaperPerson
1 Recommendation   of 4690

Coming soon: Pot chewing gum?
By Chris Kilham
Published August 31, 2012

Read more:

Maybe it just had to happen. This October, a cannabis-based chewing gum will hit marijuana dispensaries in Colorado, California, Arizona and Washington, D.C. This roll-out will follow on the heels of a dizzying array of home-made pot-based candies, baked goods, honeys, and elixirs – most of which are produced in the local areas where the cannabis shops conduct business. The gum, called Can Chew, is a collaboration of San Diego-based Medical Marijuana Inc., and Can Chew Technologies, a San Diego chewing gum technology company headquartered in the Netherlands.
Can Chew has developed a cannabis chewing gum containing Dronabinol, or THC, for people suffering from Alzheimer’s, appetite loss, multiple sclerosis and nausea. Through their technology, they are able to produce a gum that when chewed, releases fine particles of THC into the oral mucosa – the lining of the mouth – allowing for rapid absorption of the cannabis compound. According to the company, this allows for speedy relief from pain, nausea, tension and loss of appetite. According to Dr. Philip Van Damme of Can Chew, chronic pain sufferers, early and late-stage cancer patients and even anorexics can experience relief with the gum.
Cannabis has steadily emerged as a medicine for the treatment of nausea, glaucoma, pain, and a variety of neurodegenerative disorders. According to the U.S. Department of Health and Human Services, cannabis contains potent antioxidant compounds that demonstrate benefits in cases of cardiovascular disease, autoimmune disorders, inflammation, Alzheimer’s disease, Parkinson’s disease, HIV and dementia.
Medical Marijuana Inc., the first publicly held company (MJNA) devoted to cannabis, is positioning itself as the leading corporate innovator in the burgeoning cannabis product marketplace. The alliance with Can Chew is one of five strategic partnerships with entities in the cannabis medicine category. The company is also involved with cannabis cultivation, cannabis-based elixirs, cannabis dispensary retail stores, and additional cannabis medicines in other forms.
However, cannabis is illegal, and even in states where medical marijuana is state-approved, it flies in the face of federal laws regulating pot. Stepping around federal regulations with a mass-market, publicly traded product could prove very tricky. Also, cannabis is not suitable for everybody. Psychotic episodes have been reported among some cannabis users. And a recent study shows that adolescents who smoke pot and continue to do so throughout adulthood actually lose IQ points. So how do you keep Can Chew gum away from minors?
Over time, the public will have access to a broader array of cannabis-based products for various health needs. As with alcohol and prescription drugs, there are thorny issues to sort out about who should, and should not, be chewing pot gum. As local and state enforcement of anti-cannabis laws potentially continue to soften, more numbers of cannabis retail stores and more types of cannabis-based products will hit the U.S. market.
Can Chew is the first retail pot product that isn’t home-grown. Who knows what’s next after cannabis chewing gum. Could Cannabis Cola be far behind?
Chris Kilham is a medicine hunter who researches natural remedies all over the world, from the Amazon to Siberia. He teaches ethnobotany at the University of Massachusetts Amherst, where he is Explorer In Residence. Chris advises herbal, cosmetic and pharmaceutical companies and is a regular guest on radio and TV programs worldwide. His field research is largely sponsored by Naturex of Avignon, France. Read more at


Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: PaperPerson who wrote (4659)9/14/2012 5:58:14 PM
From: PaperPerson
1 Recommendation   of 4690
This Thursday piece i the L.A. TImes deals with value of a marijuana extract, CBD, to treat seizures without getting high.

Share RecommendKeepReplyMark as Last Read

From: PaperPerson9/25/2012 9:49:47 AM
   of 4690
SSL.V/SAND acting very nicely after a brief sharp pullback.

Sandstorm Gold Agrees to Purchase Precious Metals From Colossus Minerals
Vancouver, British Columbia | September 19, 2012
Sandstorm Gold Ltd. (“Sandstorm Gold” or the “Company”) (NYSE MKT: SAND, TSX-V: SSL) is pleased to announce that it has entered into a precious metals purchase agreement with Colossus Minerals Inc. (“Colossus”) (TSX: CSI) to purchase an amount of gold and platinum from the Serra Pelada Mine (“Serra Pelada”) located in Para, Brazil.

Sandstorm Gold has agreed to purchase an amount equal to 1.5% of the gold and 35% of the platinum produced from Serra Pelada (the “Precious Metals Purchase Agreement”). Pursuant to this agreement, Sandstorm Gold will pay an upfront cash deposit to Colossus of US$60 million and ongoing per ounce payments equal to the lesser of US$400 per ounce of gold and the prevailing market price of gold, and the lesser of US$200 per ounce of platinum and the prevailing market price of platinum.

“Serra Pelada is a fantastic project run by a first-class management team”, said Sandstorm Gold President & CEO Nolan Watson. “We are confident that the high-grade nature of the Serra Pelada deposit will contribute to it being a low cost producer for years to come.”

As part of the transaction, Sandstorm Gold has also agreed to purchase 35% of the palladium produced from Serra Pelada (the “Palladium Purchase Agreement”) in exchange for paying a US$15 million deposit (bringing the total deposit payment made by Sandstorm Gold to US$75 million) plus ongoing payments of US$100 per ounce of palladium. In addition, Sandstorm Gold has entered into a back-to-back agreement with Sandstorm Metals & Energy Ltd. (“Sandstorm Metals”) whereby Sandstorm Metals has purchased the Palladium Purchase Agreement from Sandstorm Gold in exchange for issuing a promissory note. The promissory note states that the US$15 million will be repaid to Sandstorm Gold in cash or shares, within one year’s time. For more information, see the Sandstorm Metals press release at

Colossus will have the option, until April 1, 2015, to purchase in whole or in part, up to 50% of the obligation to purchase metals under the Precious Metals Purchase Agreement and the Palladium Purchase Agreement by making a US$48.75 million payment, whereupon the percentage of gold and platinum to be purchased by Sandstorm Gold shall be decreased to 0.75% and 17.5% respectively and the percentage of palladium to be purchased by Sandstorm Metals shall decrease to 17.5%.

About Serra Pelada

Serra Pelada is a high-grade gold-platinum-palladium deposit located in the mineral and mining prolific Carajas region in Para State, northern Brazil. The existing infrastructure and accessibility to the site are excellent due to the close proximity of a number of major mines. During the 1980’s, Serra Pelada hosted the largest ever gold rush in Latin America with up to 80,000 artisanal miners producing 2 million ounces of gold, plus platinum and palladium, from a hand dug open pit. Colossus Minerals has been involved in the development of Serra Pelada since 2007 and is targeting initial production by the end of 2013. Serra Pelada is fully permitted and construction is underway. It is expected to be a high grade, low-cost polymetallic producer.

For more information on Serra Pelada, visit the Colossus Mineral’s website at

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10